Abstract:Introduction: Allergic reactions are mediated by human IgE antibodies that bind to and cross-link allergen molecules. The sites on allergens that are recognized by IgE antibodies have been difficult to investigate because of the paucity of IgE antibodies in a human serum. Here, we report the production of unique human IgE monoclonal antibodies to major inhaled allergens and food allergens that can be produced at scale in perpetuity. Materials and methods: The IgE antibodies were derived from peripheral blood mononuclear cells of symptomatic allergic patients, mostly children aged 3-18 years, using hybridoma fusion technology. Total IgE and allergen-specific IgE was measured by ImmunoCAP. Their specificity was confirmed through ELISA and immunoblotting. Allergenic potency measurements were determined by ImmunoCAP inhibition. Biological activity was determined in vitro by comparing β-hexosaminidase release from a humanized rat basophilic cell line. Results: Human IgE monoclonal antibodies (n = 33) were derived from 17 allergic patients with symptoms of allergic rhinitis, asthma, atopic dermatitis, food allergy, eosinophilic esophagitis, or red meat allergy. The antibodies were specific for five inhaled allergens, nine food allergens, and alpha-gal and had high levels of IgE (53,450-1,702,500 kU/L) with ratios of specific IgE to total IgE ranging from <0.01 to 1.39. Sigmoidal allergen binding curves were obtained through ELISA, with low limits of detection (<1 kU/L). Allergen specificity was confirmed through immunoblotting. Pairs of IgE monoclonal antibodies to Ara h 6 were identified that cross-linked after allergen stimulation and induced release of significant levels of β-hexosaminidase (35%-80%) from a humanized rat basophilic cell line. Conclusions: Human IgE monoclonal antibodies are unique antibody molecules with potential applications in allergy diagnosis, allergen standardization, and identification of allergenic epitopes for the development of allergy therapeutics. The IgE antibody probes will enable the unequivocal localization and validation of allergenic epitopes.

A Cell-Free Protein Synthesis Platform to Produce a Clinically Relevant Allergen Panel

Development of a protein microarray-based diagnostic chip mimicking the skin prick test for allergy diagnosis

Precision engineering for localization, validation and modification of allergenic epitopes

Rapid generation of an RBL cellular model to study proteins that cause allergenic reactions in vitro

Unique allergen-specific human IgE monoclonal antibodies derived from patients with allergic disease

Self-Assembling Allergen Vaccine Platform Raises Therapeutic Allergen-Specific IgG Responses without Induction of Systemic Allergic Responses

Molecular Allergy Diagnostics: Analytical Features That Support Clinical Decisions

Multidisciplinary Approaches to Allergies

Point-of-care personalized rapid diagnosis of allergies using peptide epitopes and SPR multiplexed detection

Use of a Rat Basophil Leukemia (RBL) Cell-Based Immunological Assay for Allergen Identification, Clinical Diagnosis of Allergy, and Identification of Anti-Allergy Agents for Use in Immunotherapy

Coupling of a Major Allergen to the Surface of Immune Cells for Use in Prophylactic Cell Therapy for the Prevention of IgE-Mediated Allergy

Synthetically glycosylated antigens as an inverse vaccine platform to prevent and treat food allergies

Innovative Systems to Deliver Allergen Powder for Epicutaneous Immunotherapy

[Microarray technique for component resolved diagnosis (CRD) in type-I allergies. An innovative technology at the border between research tool and routine diagnostics]

Identification and semi-quantification of protein allergens in complex mixtures using proteomic and AllerCatPro 2.0 bioinformatic analyses: a proof-of-concept investigation

Expression and Characterization of Functional Recombinant Bet v 1.0101 in the Chloroplast of Chlamydomonas reinhardtii

Profiling serum antibodies with a pan allergen phage library identifies key wheat allergy epitopes

Design, production and immunomodulatory potency of a novel allergen bioparticle

Allergen Microarrays and New Physical Approaches to More Sensitive and Specific Detection of Allergen-Specific Antibodies

Food allergen sensitization on a chip: the gut-immune-skin axis

Efficient experimental method for purifying allergens from aqueous extracts